Cabot (NYSE:CBT) Upgraded by UBS Group to Strong-Buy Rating

UBS Group upgraded shares of Cabot (NYSE:CBT) from a hold rating to a strong-buy rating in a report issued on Thursday, Marketbeat.com reports.

Several other equities analysts have also weighed in on CBT. Jefferies Financial Group reaffirmed a “buy” rating and set a $81.00 price objective on shares of Cabot in a research report on Thursday. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Mizuho lifted their price objective on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a research note on Thursday, December 18th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Finally, JPMorgan Chase & Co. cut their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a report on Friday, November 28th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Cabot currently has an average rating of “Hold” and a consensus price target of $74.00.

Cabot Price Performance

CBT opened at $72.80 on Thursday. The stock has a fifty day moving average price of $64.88 and a 200 day moving average price of $72.29. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. Cabot has a 1 year low of $58.33 and a 1 year high of $92.89. The stock has a market cap of $3.85 billion, a price-to-earnings ratio of 12.11, a PEG ratio of 3.76 and a beta of 0.89.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing the consensus estimate of $1.72 by ($0.02). The firm had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The business’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Analysts forecast that Cabot will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Friday, November 28th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a yield of 2.5%. Cabot’s payout ratio is currently 29.95%.

Institutional Investors Weigh In On Cabot

Hedge funds and other institutional investors have recently made changes to their positions in the business. Norges Bank acquired a new position in shares of Cabot during the 2nd quarter worth about $51,710,000. AQR Capital Management LLC increased its position in Cabot by 123.0% in the 2nd quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after buying an additional 478,702 shares during the period. UBS Group AG increased its position in Cabot by 186.7% in the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after buying an additional 386,514 shares during the period. American Century Companies Inc. lifted its holdings in shares of Cabot by 11.1% during the second quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock worth $124,855,000 after buying an additional 166,460 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in shares of Cabot by 32.5% in the first quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after acquiring an additional 108,645 shares during the period. 93.18% of the stock is owned by institutional investors and hedge funds.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.